LSoucekLab @LSoucekLab

Joined June 2023

Tweets

120
Followers

124
Following

61
Likes

417

Diario Médico @diariomedico

4 days ago

#Investigación | ➡️ @LauraSoucek, CEO de @peptomyc, transformó una idea académica en una empresa biotec que impulsa un inhibidor clínico del oncogén MYC. ✍️ @Jarreth47. diariomedico.com/medicina/inves…

0 4 6 520 0

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

3 days ago

🎙 Recuperamos capítulo #Cancer360 ‼️ 🔹 Transferencia de tecnología ¿cómo llega la investigación al paciente? 💬 @_clopez_, Mario de La Cuesta, @LauraSoucek, Joan Seoane, @HctorGPalmer2 y @adammartinsk 🎧 👉 linke.to/8oCancer360VHIO @seoanelab | @vallhebron | @iCERCA

0 4 10 499 0

Download Video

Honored to give the closing talk at the inaugural @GordonConf on #Microproteins tomorrow in Castelldefels, Spain. Excited to share our latest work on developing a clinically viable MYC inhibitor and wrap up an incredible week of cutting-edge science. @VHIO @peptomyc

1 5 36 1K 1

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

a month ago

🔬 En VHIO trabajamos para transformar los últimos hallazgos del laboratorio en #EnsayosClínicos iniciales que den lugar a mejores tratamientos para los pacientes. Ayúdanos a seguir avanzando, haz tu donación aquí 👉 linke.to/DonacionVHIO #Investigacióndelcáncer

0 3 4 395 0

Download Image

Laura Soucek @LauraSoucek

2 months ago

Thrilled to receive an @ERC_Research #ProofOfConcept grant for our #SONOMYC project! 🚀 We’ll explore ultrasound-enabled delivery of #OMO103 to the brain, targeting #MYC in primary & metastatic brain tumors. 🙏 🔗 lnkd.in/djFXaiTB @VHIO @icreacommunity @peptomyc

4 7 47 2K 0

LSoucekLab @LSoucekLab

2 months ago

What a day in the LSoucekLab! Fabio Giuntini defended his PhD and made us all proud. Big thanks to @SaraSdelci, Judit Balmaña and Stefano Campaner for being part of the PhD thesis committee. Congratulations, Dr Giuntini!

0 0 19 304 0

Download Image

LSoucekLab @LSoucekLab

3 months ago

We are proud to announce that our PhD student, @dcapi14, presented yesterday a poster at #EACR2025 in Lisbon titled “MYC targeting by Omomyc boosts efficacy and overcomes resistance to KRAS inhibitors”. Well done, Dani! @VHIO @EACRnews #cancer

0 3 15 963 0

Download Image

PEPTOMYC @peptomyc

3 months ago

Our CEO @LauraSoucek and our CSO @mebeaulieu are at #BIO2025 in Boston! Let’s connect and talk MYC inhibition and novel cancer therapies. #Peptomyc #oncology #VHIO

0 3 19 647 0

Download Image

LSoucekLab @LSoucekLab

4 months ago

Proud to see our @ignigor presenting a poster about the therapeutic impact and reactivation of tumor immunity by MYC inhibition in KRAS-driven NSCLC with diverse mutational profiles at the #EACR Congress: Defence is the best attack: Immuno-Oncology Breakthroughs 2025. Great work!

0 2 11 441 1

Download Image

Manuel Valiente @valientelab

4 months ago

This is definitely something to cellebrate! A triumph of science: a real impact on a baby that did not have any chance to make it. So inspiring. I hope also inspiring to those that question the role science must have in all societies. Long live to KJ! nytimes.com/2025/05/15/hea…

0 10 43 2K 2

LSoucekLab @LSoucekLab

4 months ago

Wonderful presentation by Fabio Giuntini at #AACR25 in the minisymposium Experimental Therapeutics: Drug Resitance, talking about Omomyc synergy with PARPi in PARPi-resistant TNBC. We are so proud! @VHIO

1 3 17 842 0

Download Image

LSoucekLab @LSoucekLab

4 months ago

Our PhD student (not for much longer!), Fabio Giuntini, just presented a poster at #AACR25 regarding DNA damage modulation by MYC inhibition as a new therapeutic opportunity in TNBC. He’s also been selected for an oral presentation tomorrow. Stay tuned! @VHIO

0 4 28 852 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

4 months ago

#AACR25 | On Tuesday, April 29, at @AACR, Fabio Giuntini, researcher in VHIO’s Models of Cancer Therapies Group, will present on how Omomyc synergizes with PARPi and reverts resistance to therapy in multiple PARPi-resistant triple-negative breast cancer models.

0 2 12 845 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

4 months ago

#AACR25 | @LauraSoucek, Director of VHIO’s Preclinical and Translational Research Program, has chaired and spoken at the @AACR Annual Meeting on strategies to target MYC, one of the most challenging targets in cancer research. #CancerResearch

0 6 28 1K 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

5 months ago

VHIO researchers @LauraSoucek, @seoanelab, @RToledoLab & Julia Montoro participated in the @Amgen Partners of Choice meeting in Reykjavík to share projects, foster collaboration, and accelerate new cancer therapies. Teamwork and innovation are key to improving patient outcomes‼️

0 3 23 905 0

Download Image

LSoucekLab @LSoucekLab

5 months ago

Spring has sprung: @LSoucekLab and @peptomyc celebrate their annual calçotada/asado with friends, spouses, kids and dogs. <3

0 3 12 634 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

5 months ago

¿Sabías que el plasma es clave para muchos tratamientos médicos❓ En VHIO nos sumamos al #RepteDor @donarsang para aumentar las donaciones de plasma en Cataluña 👇 #ViuiFesViure

0 5 11 589 1

Download Video

LSoucekLab @LSoucekLab

6 months ago

Congratulations to our @dcapi14 for being awarded a @FundlaCaixa PhD fellowship! We are all proud of you 👏

0 2 10 436 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

6 months ago

#ESMOTAT25 📣 The corporate and investor mindset: What types of anticancer drugs and clinical research proposals will be prioritized in the near term? 💬 @LauraSoucek, Cristian Massacesi, Shaily Arora, @GruenbaumYael & Giovanni Abbadessa. 👉 esmo.org/meeting-calend…

0 3 5 552 0

Download Image

Vall d’Hebron Institute of Oncology (VHIO) @VHIO

7 months ago

#MYC: de diana terapèutica intractable als primers assaigs clínics en pacients amb càncer 🔬 @LauraSoucek i @jonywhitfield han coliderat un article publicat a @NatRevDrugDisc que analitza els esforços de la comunitat científica per desenvolupar aquest fàrmac. ➡️…